These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 9022624)

  • 1. Ability of an anti-luteinizing hormone-releasing hormone vaccine to inhibit gonadotropins in postmenopausal women.
    Gual C; Garza-Flores J; Menjivar M; Gutierrez-Najar A; Pal R; Talwar GP
    Fertil Steril; 1997 Feb; 67(2):404-7. PubMed ID: 9022624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subcutaneous administration of pulsatile gonadotropin-releasing hormone decreases serum follicle-stimulating hormone and luteinizing hormone levels in women with polycystic ovary syndrome: a preliminary study.
    Graña-Barcia M; Liz-Lestón J; Lado-Abeal J
    Fertil Steril; 2005 May; 83(5):1466-72. PubMed ID: 15866586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early and late hormonal responses to the microdose gonadotropin-releasing hormone agonist in normal menstruating women.
    Park WI; Kim SS; Chung HR; Shin SY; Lee JY
    Fertil Steril; 2004 Apr; 81(4):1067-72. PubMed ID: 15066465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The serum follicle-stimulating hormone-to-luteinizing hormone ratio at the start of stimulation with gonadotropins after pituitary down-regulation is inversely correlated with a mature oocyte yield and can predict "low responders".
    Ho JY; Guu HF; Yi YC; Chen MJ; Ho ES
    Fertil Steril; 2005 Apr; 83(4):883-8. PubMed ID: 15820795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum estradiol and gonadotropins level in postmenopausal women with or without hormone replacement.
    Limpaphayom K; Taechakraichana N; Kittinunvorakoon C
    J Med Assoc Thai; 1997 Mar; 80(3):147-52. PubMed ID: 9175381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of clomiphene and raloxifene on gonadotrophin secretion in postmenopausal women: evidence of nongenomic action.
    Garas A; Trypsianis G; Kallitsaris A; Milingos S; Messinis IE
    Clin Endocrinol (Oxf); 2004 Aug; 61(2):256-62. PubMed ID: 15272923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Follicular phase serum levels of luteinizing hormone do not influence delivery rates in in vitro fertilization cycles down-regulated with a gonadotropin-releasing hormone agonist and stimulated with recombinant follicle-stimulating hormone.
    Cabrera RA; Stadtmauer L; Mayer JF; Gibbons WE; Oehninger S
    Fertil Steril; 2005 Jan; 83(1):42-8. PubMed ID: 15652885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estradiol, FSH and LH profiles in nine ethnic groups of postmenopausal Asian women: the Pan-Asia Menopause (PAM) study.
    Ausmanas MK; Tan DA; Jaisamrarn U; Tian XW; Holinka CF
    Climacteric; 2007 Oct; 10(5):427-37. PubMed ID: 17852146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The predictive value of double Gn-RH provocation test in unprimed Gn-RH-primed and steroid-primed female patients with Kallmann's syndrome.
    Chryssikopoulos A; Gregoriou O; Vitoratos N; Rizos D; Papadias K
    Int J Fertil Womens Med; 1998; 43(6):291-9. PubMed ID: 9920538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time course of serum testosterone and luteinizing hormone levels after cessation of long-term luteinizing hormone-releasing hormone agonist treatment in patients with prostate cancer.
    Kaku H; Saika T; Tsushima T; Ebara S; Senoh T; Yamato T; Nasu Y; Kumon H
    Prostate; 2006 Mar; 66(4):439-44. PubMed ID: 16329145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Equivalence of the 3-month and 28-day formulations of triptorelin with regard to achievement and maintenance of medical castration in women with endometriosis.
    Donnez J; Dewart PJ; Hedon B; Perino A; Schindler AE; Blumberg J; Querleu D
    Fertil Steril; 2004 Feb; 81(2):297-304. PubMed ID: 14967363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occurrence of postmenopausal-like acidic follicle-stimulating hormone (FSH) isoforms precedes the rise of FSH before menopause.
    Thomas CM; Span PN; Smeenk JM; Hanssen RG; Braat DD; Sweep FC
    Fertil Steril; 2009 Aug; 92(2):613-9. PubMed ID: 18692804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adequate reduction degree of pituitary gonadotropin levels in the clinical management of short-term hormone replacement therapy of women with menopausal symptoms.
    Ushiroyama T; Sakuma K; Ikeda A; Ueki M
    J Med; 2004; 35(1-6):281-94. PubMed ID: 18084886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical effects of ovulation induction with recombinant follicle-stimulating hormone supplemented with recombinant luteinizing hormone or low-dose recombinant human chorionic gonadotropin in the midfollicular phase in microdose cycles in poor responders.
    Berkkanoglu M; Isikoglu M; Aydin D; Ozgur K
    Fertil Steril; 2007 Sep; 88(3):665-9. PubMed ID: 17292895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum follicle-stimulating hormone and luteinizing hormone levels in women aged 35-60 in the U.S. population: the Third National Health and Nutrition Examination Survey (NHANES III, 1988-1994).
    Backer LC; Rubin CS; Marcus M; Kieszak SM; Schober SE
    Menopause; 1999; 6(1):29-35. PubMed ID: 10100177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential regulation of two forms of gonadotropin-releasing hormone messenger ribonucleic acid by gonadotropins in human immortalized ovarian surface epithelium and ovarian cancer cells.
    Choi JH; Choi KC; Auersperg N; Leung PC
    Endocr Relat Cancer; 2006 Jun; 13(2):641-51. PubMed ID: 16728589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of synthetic LH-RH on serum LH and FSH levels in patients with second grade amenorrhea.
    Kato H; Kido Y; Ito T; Torigoe T; Suetsugu N
    Acta Obstet Gynaecol Jpn; 1973 Jul; 20(3):137-40. PubMed ID: 4617476
    [No Abstract]   [Full Text] [Related]  

  • 18. Elevated day 3 follicle-stimulating hormone/luteinizing hormone ratio >or= 2 is associated with higher rates of cancellation in in vitro fertilization-embryo transfer cycles.
    Liu KE; Greenblatt EM
    Fertil Steril; 2008 Aug; 90(2):297-301. PubMed ID: 18023434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum luteinizing hormone, follicle-stimulating hormone and oestradiol pattern in women undergoing pituitary suppression with different gonadotrophin-releasing hormone analogue protocols for assisted reproduction.
    Manna C; Rahman A; Sbracia M; Pappalardo S; Mohamed EI; Linder R; Nardo LG
    Gynecol Endocrinol; 2005 Apr; 20(4):188-94. PubMed ID: 16019360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First human exposure to exogenous single-dose oral estetrol in early postmenopausal women.
    Visser M; Holinka CF; Coelingh Bennink HJ
    Climacteric; 2008; 11 Suppl 1():31-40. PubMed ID: 18464021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.